FDA 510(k)

STA® - Liquid Anti-Xa

K号: K260214 · 2026-09-24

决定日期2026-09-24

产品代码KFF

咨询委员会HE

决定Substantially Equivalent

器械摘要

STA® - Liquid Anti-Xa is the device name listed in this FDA 510(k) record. The listed applicant is Diagnostica Stago, Inc.. It received FDA 510(k) clearance on 2026-09-24 under 510(k) number K260214. The device is classified under product code KFF. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the STA® - Liquid Anti-Xa?

STA® - Liquid Anti-Xa is a medical device that received FDA 510(k) clearance on 2026-09-24. The listed applicant is Diagnostica Stago, Inc.. The 510(k) number is K260214.

When did STA® - Liquid Anti-Xa receive FDA 510(k) clearance?

STA® - Liquid Anti-Xa received FDA 510(k) clearance on 2026-09-24, under 510(k) number K260214.

Who is the listed applicant for STA® - Liquid Anti-Xa?

The FDA 510(k) record lists Diagnostica Stago, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for STA® - Liquid Anti-Xa?

The FDA product code for STA® - Liquid Anti-Xa is KFF.

列明Diagnostica Stago, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K253658STA Satellite Max®

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。